A major loss in the share price of oil exploration company Cairn Energy along with AstraZeneca pulled the FTSE 100 index back under 4,700 after a stronger week.
The FTSE 100 index eventually closed down 38.4 points or 0.81% to 4,696.8 after Cairn Energy announced its exploration of Rajasthan will now generate lower reserves than initially estimated – down to around one-fifth of predicted reserves - along with the threat of a royalty tax worth $3 a barrel by the Indian government. This dragged Cairn’s share value down a whopping 247p or 18% to £11.15. European drugs firm AstraZeneca also lost 170p or 8.2% to £18.86 after announcing its Iressa lung cancer drug didn't help patients as hoped, when trialled in its study, pulling rival firm GlaxoSmith...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes